Navigating an Increasingly Complex
Treatment Paradigm in the Management of Multiple Sclerosis (MS): Key
Considerations in Managed Care Decision-Making
A continuing medical education
activity provided by NAMCP and AAMCN
This activity is an archive from the live session from the 2023
Spring Managed Care Forum. If you participated in the live session,
you are not eligible for continuing education credits from this
archive.
This activity is valid from June 1, 2023 to August 1, 2024
|
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
|
Audience:
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
educational grants from
Bristol Myers Squibb and Sanofi
Description:
Multiple Sclerosis (MS) is a chronic progressive disease. It is the
most common neurological cause of disability among young adults,
with a prevalence of approximately 1 million cases throughout the
United States, and every week around 200 people are diagnosed with
the disease. Although there is still no cure for MS, many advances
in MS treatment have arrived in recent years, allowing patients to
manage these symptoms and improve their quality of life. A number of
factors must be considered when selecting a treatment regimen for
patients with MS, including variations in clinical and MRI evidence
of disease. Over the past decade, there have been numerous revisions
to MS diagnostic criteria and the development of multiple new and
emerging therapies. While the explosion of these emerging therapies
have shown the ability to improve outcomes and quality of life in
patient's MS, it makes staying current with best practices a
challenge that must be overcome through education. New options
showing improved efficacy, safety and deliverability have arrived
and it is for this reason that medical directors, neurologists,
practicing physicians, nurse case managers and other healthcare
professionals must be updated on the current and emerging treatments
and strategies in the management of MS.
Upon completion of this
activity, participants will be able to:
-
Break down the current treatment
challenges and unmet needs in managing multiple sclerosis (MS)
and the burden on patients and the healthcare system
-
Examine the clinical presentation,
classification, and diagnostic challenges of MS
-
Analyze the efficacy, safety, and
dosing/administration of current and emerging MS therapies and
their effect on staging and sequencing
-
Compare and contrast S1P therapies
for the treatment of relapsing and progressive forms MS
-
Analyze the evolving role of BTK
inhibitors in the management of relapsing MS patients with
highly active disease
-
Evaluate actions plans to close
identified gaps in risk stratification, patient-centered
treatment, and inequities in care for diverse patient
populations
Faculty: |
Gary Owens, MD
President
Gary Owens Associates |
Disclosure:
|
(Relevant Financial Relationships with Ineligible
Companies in the Last 24 Months):
Dr. Owens has served as a consultant for Sanofi and
Regeneron. His presentation has been reviewed for any
bias. |
Planning Committee: |
Bill
Williams, MD has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jeremy Williams has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial
relationships with an ineligible company in the last 24
months to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity. |
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is supported by educational grants from
Bristol Myers Squibb and Sanofi
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
professional.
Click Here To Continue |